Latest Insider Transactions at Elanco Animal Health Inc (ELAN)
This section provides a real-time view of insider transactions for Elanco Animal Health Inc (ELAN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Elanco Animal Health Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Elanco Animal Health Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
De Simas Jose Manuel Correia |
BUY
Grant, award, or other acquisition
|
Direct |
14,432
+30.66%
|
-
|
|
Mar 01
2023
|
De Simas Jose Manuel Correia |
SELL
Payment of exercise price or tax liability
|
Direct |
1,400
-7.14%
|
$15,400
$11.26 P/Share
|
|
Feb 01
2023
|
Todd S. Young |
BUY
Conversion of derivative security
|
Indirect |
1,562
+19.23%
|
-
|
|
Jan 03
2023
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-2.08%
|
$4,824
$12.35 P/Share
|
|
Nov 30
2022
|
John P Bilbrey |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+31.88%
|
-
|
|
Nov 30
2022
|
Lawrence Erik Kurzius |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+26.06%
|
-
|
|
Nov 30
2022
|
R David Hoover |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+24.36%
|
-
|
|
Nov 30
2022
|
Kapila K Anand |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+28.79%
|
-
|
|
Nov 30
2022
|
Denise Scots Knight |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+31.88%
|
-
|
|
Nov 30
2022
|
Kirk P Mc Donald |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+31.88%
|
-
|
|
Nov 30
2022
|
Deborah Turner Kochevar |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+31.34%
|
-
|
|
Nov 30
2022
|
Michael J Harrington |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+25.63%
|
-
|
|
Nov 30
2022
|
Art A Garcia |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+30.54%
|
-
|
|
Nov 30
2022
|
William F Doyle |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+41.81%
|
-
|
|
Nov 30
2022
|
Paul Herendeen |
BUY
Grant, award, or other acquisition
|
Direct |
18,649
+34.15%
|
-
|
|
Nov 11
2022
|
John P Bilbrey |
BUY
Open market or private purchase
|
Indirect |
7,500
+15.24%
|
$97,500
$13.24 P/Share
|
|
Nov 01
2022
|
Ellen De Brabander |
SELL
Payment of exercise price or tax liability
|
Direct |
11,295
-18.78%
|
$146,835
$13.28 P/Share
|
|
Sep 09
2022
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
20,000
+12.12%
|
$300,000
$15.18 P/Share
|
|
Sep 09
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
BUY
Open market or private purchase
|
Indirect |
30,000
+50.0%
|
$420,000
$14.54 P/Share
|
|
Sep 09
2022
|
Rajeev A. Modi |
BUY
Open market or private purchase
|
Direct |
6,700
+14.0%
|
$93,800
$14.9 P/Share
|
|
Sep 09
2022
|
Paul Herendeen |
BUY
Open market or private purchase
|
Direct |
10,000
+36.62%
|
$150,000
$15.03 P/Share
|
|
Jul 01
2022
|
Marcela A. Kirberger |
SELL
Payment of exercise price or tax liability
|
Direct |
1,868
-9.75%
|
$37,360
$20.62 P/Share
|
|
Jul 01
2022
|
De Simas Jose Manuel Correia |
SELL
Payment of exercise price or tax liability
|
Direct |
2,172
-9.97%
|
$43,440
$20.62 P/Share
|
|
May 20
2022
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
10,000
+7.41%
|
$230,000
$23.33 P/Share
|
|
May 11
2022
|
John P Bilbrey |
BUY
Open market or private purchase
|
Indirect |
10,000
+22.61%
|
$220,000
$22.03 P/Share
|
|
Apr 01
2022
|
Rajeev A. Modi |
BUY
Grant, award, or other acquisition
|
Direct |
34,457
+50.0%
|
-
|
|
Mar 05
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
10,688
-1.4%
|
$288,576
$27.95 P/Share
|
|
Mar 02
2022
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-1.43%
|
$8,149
$29.0 P/Share
|
|
Mar 02
2022
|
David Alan Urbanek |
SELL
Payment of exercise price or tax liability
|
Direct |
961
-1.03%
|
$27,869
$29.0 P/Share
|
|
Mar 02
2022
|
David S Kinard |
SELL
Payment of exercise price or tax liability
|
Direct |
874
-0.92%
|
$25,346
$29.0 P/Share
|
|
Mar 02
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
8,879
-1.15%
|
$257,491
$29.0 P/Share
|
|
Mar 02
2022
|
Ramiro Martin Cabral |
SELL
Payment of exercise price or tax liability
|
Direct |
1,251
-1.49%
|
$36,279
$29.0 P/Share
|
|
Mar 02
2022
|
Todd S. Young |
SELL
Payment of exercise price or tax liability
|
Direct |
2,135
-1.75%
|
$61,915
$29.0 P/Share
|
|
Mar 02
2022
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
5,000
+4.17%
|
$145,000
$29.0 P/Share
|
|
Mar 01
2022
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-1.92%
|
$10,724
$28.94 P/Share
|
|
Mar 01
2022
|
James M Meer CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,955
+12.88%
|
-
|
|
Mar 01
2022
|
Kapila K Anand |
BUY
Open market or private purchase
|
Direct |
1,000
+3.51%
|
$28,000
$28.48 P/Share
|
|
Mar 01
2022
|
Ellen De Brabander |
BUY
Grant, award, or other acquisition
|
Direct |
14,496
+19.42%
|
-
|
|
Mar 01
2022
|
David Alan Urbanek |
SELL
Payment of exercise price or tax liability
|
Direct |
1,800
-1.89%
|
$50,400
$28.94 P/Share
|
|
Mar 01
2022
|
David Alan Urbanek |
BUY
Grant, award, or other acquisition
|
Direct |
10,341
+9.81%
|
-
|
|
Mar 01
2022
|
Marcela A. Kirberger |
BUY
Grant, award, or other acquisition
|
Direct |
10,583
+35.59%
|
-
|
|
Mar 01
2022
|
David S Kinard |
SELL
Payment of exercise price or tax liability
|
Direct |
1,724
-1.77%
|
$48,272
$28.94 P/Share
|
|
Mar 01
2022
|
David S Kinard |
BUY
Grant, award, or other acquisition
|
Direct |
8,665
+8.18%
|
-
|
|
Mar 01
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
5,031
-0.65%
|
$140,868
$28.94 P/Share
|
|
Mar 01
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
88,114
+10.18%
|
-
|
|
Mar 01
2022
|
De Simas Jose Manuel Correia |
SELL
Payment of exercise price or tax liability
|
Direct |
573
-2.56%
|
$16,044
$28.94 P/Share
|
|
Mar 01
2022
|
De Simas Jose Manuel Correia |
BUY
Grant, award, or other acquisition
|
Direct |
5,123
+18.65%
|
-
|
|
Mar 01
2022
|
Ramiro Martin Cabral |
SELL
Payment of exercise price or tax liability
|
Direct |
1,892
-2.2%
|
$52,976
$28.94 P/Share
|
|
Mar 01
2022
|
Ramiro Martin Cabral |
BUY
Grant, award, or other acquisition
|
Direct |
12,699
+12.86%
|
-
|
|
Mar 01
2022
|
Todd S. Young |
SELL
Payment of exercise price or tax liability
|
Direct |
3,747
-2.98%
|
$104,916
$28.94 P/Share
|